Sunitinib selectively targets leukemogenic signaling of mutant SHP2 in juvenile myelomonocytic leukemia.
He C, Peng Z, Zhang D, Guo Y, Liang T, Zhao Y, Yu L, Zhang Q, Chang Z, Xiao Y, Li N, Xue H, Wu S, Zhao ZJ, Zhang C, Chen Y.
He C, et al. Among authors: xiao y.
Biochem Pharmacol. 2023 Jul;213:115588. doi: 10.1016/j.bcp.2023.115588. Epub 2023 May 13.
Biochem Pharmacol. 2023.
PMID: 37187274
Free article.